Peter van Ruitenbeek, assistant professor at our Department, gave a talk about what addiction actually entails beyond the conventional narrative focused on the acute increase in dopamine levels that substances of abuse cause. Here is a summary of his interesting presentation hosted by the 2022 edition of the Pleasure, Art and Science Festival 2022. In… Continue reading Addiction – The realm of myth
On September 28 uniMIND Central Session will host Mauro Cavarra for an open discussion on our recently published paper reviewing the different models of psychedelic-assisted psychotherapy used in clinical trials. The session will start at 7pm (CEST) and anyone is welcome to join via the MIND Community Platform.
Do psychedelics work for chronic pain? We asked the patients themselves! In our recent article we present the results of a survey study addressed to chronic pain sufferers who are using psychedelics (both in full doses and in microdoses) to seek relief. Our results support the hypothesis that both dosing regimens hold promise for chronic… Continue reading Analgesic potential of psychedelics in chronic pain sufferers: a population survey
It is with great joy that we post some of the photos take on the May 2022 edition of the Neuropsychology and Psychopharmacology Research Day. The event was a great opportunity to showcase all the research lines that are being pursued by each team, to exchange ideas in an open and welcoming atmosphere, to meet… Continue reading Research day May 2022
SSRIs are still widely prescribed to treat various psychiatric indications even in older adults. The side effects of SSRIs have been characterized in younger adults, but this is not the case for older adults. One concern is that SSRI treatment may contribute to a deterioration of cognitive performance in this older patient population. This systematic… Continue reading The effects of selective serotonin reuptake inhibitors on memory functioning in older adults: A systematic literature review